DCIS grading schemes and clinical implications (Q33785753)

29 July 2017

1 reference

title

DCIS grading schemes and clinical implications (English)

1 reference

29 July 2017

Shoker BS

1

1 reference

29 July 2017

Sloane JP

series ordinal

2

1 reference

29 July 2017

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

35

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

393-400

1 reference

Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

The influence of margin width on local control of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Intraductal carcinoma of the breast: Follow-up after biopsy only

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Heterogeneity of intraductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

A prognostic index for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.035005393.X

10.1046/J.1365-2559.1999.035005393.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference